Founded in 1980, Atlas Venture has organized seven international funds, and currently manages over $2.0 billion in committed capital, including a $600 million fund raised in April 2001. The Atlas Venture investment team is comprised of operating executives and career venture capitalists who have been involved with more than 350 companies in more than 16 different countries. Since 1995, 50 of Atlas' companies have been acquired and 40 are public. The firm prefers to invest in companies at their earliest stage and focuses on the life sciences and technology industries. Typical investments range from $500,000 to $5 million. Its most current fund, Atlas Venture VIII, is a 2009 vintage for which it held a single close at $283 million. The firm has divided into separate Life Sciences and Technology teams. The Life Sciences group will retain the Atlas name.
Firm Location:Massachusetts • New York, New York • Boston, Massachusetts • Cambridge, Massachusetts • Boston / New England
Investor Firms That Co-Invest with Atlas Venture
SR OneInterWestCota CapitalMPM CapitalJohnson & Johnson InnovationRoche Venture FundF-Prime Capital PartnersSea Lane VenturesKapor CapitalForesite CapitalGVPivotal bioVenture PartnersCraft VenturesNovartis Venture FundSV Health InvestorsWalden InternationalBreakthrough Energy VenturesOrbiMedThe Column GroupPlayground GlobalPolaris PartnersARCH Venture PartnersThird Rock VenturesAutoTech VenturesYsios CapitalHatteras Venture PartnersThe House FundSV AngelGE VenturesNew Enterprise Associates (NEA)DCVC (Data Collective)Aditum BioBessemer Venture PartnersCanaan PartnersFelicis VenturesGreylockRedpoint VenturesKurma PartnersSoffinova PartnersLightstone VCLongwood FundNest.Bio LabsBroadview VenturesvenBioAltitude Life Science Ventures (ALSV)ForbionOmega FundsAndera PartnersAccess BiotechnologyBorealis VenturesAdvent Life Sciences5am VenturesM Ventures (Merck)
Atlas Venture Team